← Eichor
Condition: Psoriatic Arthritis Psa Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Psoriatic Arthritis Psa

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Preventing Structural Damage in Early Psoriatic Arthritis
Phase 4 · 1 location(s) · Chinese University of Hong Kong · NCT07486843Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
Phase 3 · 14 location(s) · University of Pennsylvania · NCT05669833Oxidative Stress in Autoimmune Rheumatic Diseases
Phase N/A · 1 location(s) · University of Thessaly · NCT07536529Efficacy Of Upadacitinib In Psoriatic Arthritis And Comparison To Rheumatoid Arthritis.
Phase N/A · 14 location(s) · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · NCT06630715Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis
Phase 1 · 1 location(s) · LAPIX Therapeutics Inc. · NCT06628206REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
Phase 4 · 7 location(s) · Sint Maartenskliniek · NCT07160231Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PRE
Phase 4 · 17 location(s) · Instituto de Investigación Marqués de Valdecilla · NCT07611747Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Phase 3 · 16 location(s) · Takeda · NCT07286058A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx®
Phase 1 · 14 location(s) · UCB Biopharma SRL · NCT06888193A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psori
Phase 4 · 55 location(s) · Eli Lilly and Company · NCT06864026Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis
Phase N/A · 1 location(s) · Charite University, Berlin, Germany · NCT07298265APACHE Cohort (A Psoriatic Arthritis CoHort)
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT03768271A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis
Phase 2 · 1 location(s) · InventisBio Co., Ltd · NCT07315061HIPPOCRATES Prospective Observational Study
Phase N/A · 1 location(s) · University of Oxford · NCT05858528Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
Phase 1 · 2 location(s) · Seismic Therapeutic AU Pty Ltd · NCT07455578Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
NA · 4 location(s) · NHS Greater Glasgow and Clyde · NCT07443956Modifying PEST for Psoriatic Arthritis Screening
NA · 30 location(s) · Novartis Pharmaceuticals · NCT06382051A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Phase 3 · 188 location(s) · Takeda · NCT06671483COMFI - a COMbined Fatigue Intervention
NA · 2 location(s) · The Danish Center for Expertise in Rheumatology · NCT06666452A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
Phase 4 · 10 location(s) · Johnson & Johnson Private Limited · NCT07141004Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Phase N/A · 1 location(s) · University of Bonn · NCT07150000A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With
Phase 3 · 47 location(s) · Bristol-Myers Squibb · NCT06869551Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Phase 4 · 2 location(s) · University of Sao Paulo General Hospital · NCT07087912Sex and Gender-based Analysis of the Effectiveness of Advanced Therapies in Psoriatic Arthritis
Phase N/A · 1 location(s) · Women's College Hospital · NCT05954364AYLo - AutoimmunitY and Loss of y
Phase N/A · 1 location(s) · University of Bonn · NCT06696027Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
NA · 1 location(s) · University of California, San Diego · NCT06586281Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upada
Phase N/A · 1 location(s) · Adelphi Real World · NCT07166315A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · 122 location(s) · Takeda · NCT06671496A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting
Phase N/A · 21 location(s) · Janssen Research & Development, LLC · NCT07220824
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.